University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Phase 2

Withdrawn

Conditions: Thrombotic Microangiopathies
Neuroblastoma
Transplant-Associated Thrombotic Microangiopathy
High-risk Neuroblastoma

Interventions: Drug: Defibrotide

First Posted Date: 2023-12-26

Last Posted Date: 2024-08-07

Lead Sponsor: University of California, San Francisco

Registration Number: NCT06182410

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

Not Applicable

Recruiting

Conditions: Hepatitis C

Interventions: Behavioral: Partner Navigation Intervention

First Posted Date: 2023-12-22

Last Posted Date: 2024-03-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 250

Registration Number: NCT06179498

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

BRSR: Feasibility and Acceptability Pilot

Not Applicable

Recruiting

Conditions: Older Adults
Postoperative Outcome
Depressive Symptoms
Physical Function
Psychosocial Functioning
Surgery

Interventions: Behavioral: Problem Solving Therapy (PST)

First Posted Date: 2023-12-18

Last Posted Date: 2024-07-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 90

Registration Number: NCT06174701

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Smoke-free Home Study in Subsidized Housing

Not Applicable

Recruiting

Conditions: Tobacco Dependence
Tobacco Smoking

Interventions: Behavioral: Smoke-free home resident intervention
Behavioral: Lay Health Worker coaching

First Posted Date: 2023-12-14

Last Posted Date: 2024-07-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 544

Registration Number: NCT06170437

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer
Prostate Cancer Metastatic

Interventions: Other: Counseling Tool
Other: Questionnaires

First Posted Date: 2023-12-14

Last Posted Date: 2023-12-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT06171139

Locations: 🇺🇸
University of California, San Francisco, California, United States

Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis

Not Applicable

Recruiting

Conditions: Non-cystic Fibrosis Bronchiectasis

Interventions: Behavioral: Support Group

First Posted Date: 2023-12-11

Last Posted Date: 2024-05-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 40

Registration Number: NCT06164470

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

Phase 2

Recruiting

Conditions: Hemophagocytic Lymphohistiocytoses

Interventions: Drug: Ruxolitinib
Drug: Etoposide
Drug: Dexamethasone
Procedure: Non-interventional Imaging
Procedure: Research Biopsy
Procedure: Biospecimen Collection

First Posted Date: 2023-12-07

Last Posted Date: 2024-10-15

Lead Sponsor: Aaron Logan, MD

Target Recruit Count: 36

Registration Number: NCT06160791

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Not Applicable

Completed

Conditions: COVID-19

Interventions: Behavioral: Vaccine Acceptance Question
Behavioral: Vaccine Messaging

First Posted Date: 2023-12-05

Last Posted Date: 2024-10-29

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 852

Registration Number: NCT06156215

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Jefferson Methodist Hospital, Philadelphia, Pennsylvania, United States

and more 4 locations

The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

Phase 4

Recruiting

Conditions: Asthma
COPD

Interventions: Drug: n-acetylcystine (NAC)+ albuterol
Device: AeroEclipse-VersaPAP System

First Posted Date: 2023-12-01

Last Posted Date: 2024-10-22

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT06152653

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

UCSF BP Activate Letter Study

Not Applicable

Active, not recruiting

Conditions: Hypertension

Interventions: Other: Control Letter
Other: BP Activate Letter

First Posted Date: 2023-11-30

Last Posted Date: 2024-08-07

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 484

Registration Number: NCT06152094

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy